Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
about
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibioticsCarbapenems: past, present, and futureMK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus sppN-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaPharmacokinetics of imipenem and cilastatin in patients with cystic fibrosisN-formimidoyl thienamycin (MK0787): in vitro study.In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazoleActivity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains.
P2860
Q24628883-F7BDEFB7-CEB9-468D-B118-2B436BD456CBQ24634999-664B2DD0-13FC-4C9B-9C0D-82B7E10882A8Q33730227-36949B41-59AC-4556-9438-EBAC4F288F5CQ35668463-19654200-6CE9-4E56-A09F-EAD79657DB59Q35673370-6F48AB58-3C88-4626-8642-8D033632DE1CQ39849680-CB6D427C-20C4-417C-9E7E-31A188121BACQ39854470-152F250C-12C3-43F9-8B66-65B59A66C370Q39854523-1507E827-0719-492F-B647-96D167C3FE4FQ39855480-410811BF-E8C5-463E-8B69-BF5EB28C4CE9Q39856399-D4D73B34-A39E-4CC6-879F-1A7561D50CEBQ39856698-3B89101F-44AA-47F9-B949-D0073C02DB77Q39856708-50518AC3-E234-48AF-AC77-8E483B1170C0Q39856722-D908534C-77D1-41FF-B5ED-50CA2ACD3EC3Q39857062-ED8E3FF2-6940-4DE3-A39E-DBC05AB019E2Q40270998-B7556420-A4E8-4D1D-AD0C-11DBBEAEB307Q40281731-A2E9C1FA-AB75-4855-9B5F-D885802CE464Q40282937-1069DD05-FD93-49E4-8C53-9741B122C2B6Q40283220-01E7B00E-4C5B-4D91-B870-C9D621DD0E40
P2860
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@ast
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@en
type
label
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@ast
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@en
prefLabel
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@ast
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@en
P2093
P2860
P356
P1476
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity
@en
P2093
P2860
P304
P356
10.1128/AAC.15.4.518
P407
P577
1979-04-01T00:00:00Z